At a glance
- Originator Nonindustrial source
- Class Antibacterials; Antineoplastics; Rifamycins
- Mechanism of Action Protein 50S ribosomal subunit inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Mycobacterium avium complex infections; Tuberculosis